- Home
- SANA vs MBIN Comparison
SANA vs MBIN Comparison
Compare SANA & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SANA | MBIN |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SANA | MBIN |
|---|---|---|
| Price | $3.15 | $42.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $7.50 | ★ $43.67 |
| AVG Volume (30 Days) | ★ 1.8M | 463.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | ★ 17.24 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $31.76 |
| Revenue Next Year | N/A | $3.73 |
| P/E Ratio | ★ N/A | $12.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $27.25 |
| 52 Week High | $6.55 | $48.50 |
Technical Indicators
Market Signals| Indicator | SANA | MBIN |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 48.17 |
| Support Level | $2.85 | $30.89 |
| Resistance Level | $3.24 | $48.50 |
| Average True Range (ATR) | 0.26 | 1.42 |
| MACD | -0.08 | -0.55 |
| Stochastic Oscillator | 6.42 | 29.83 |
Price Performance
Historical ComparisonAbout SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About MBIN Merchants Bancorp
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.